Particulars |
|
|
|
Company Name
| Cohance Lifesciences Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
38.26 |
B.V. (₹) |
60.90 |
Sales(₹ Cr.) |
1,093.51 |
NP (₹ Cr.) |
271.77 |
NP Var (%) |
-8.00 |
Div% |
0.00 |
CPS(₹) |
8.60 |
EPS (₹) |
7.10 |
Traded Value(₹ Lakhs) |
10,506.91 |
52 Week High |
1,359.00 |
52 Week Low |
857.00 |
Price BSE |
914.00 |
Price NSE |
913.00 |
Market Capital (₹ Cr.) |
34,972.38 |
P/C Ratio |
106.30 |
P/E Ratio |
128.70 |
Price Vs.BV |
15.01 |
|
Latest Quarter |
Year End |
202506 |
Sales (₹ Cr.) |
483.58 |
NP(₹ Cr.) |
58.56 |
NP Var % |
-22.00 |
Trailing Twelve Months |
Year End |
202506 |
Sales |
914.50 |
OPM |
38.18 |
NP |
247.20 |
NP Var (%) |
38.03 |
EPS |
9.23 |
PE |
99.04 |
|
|